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Chemical and Biological Investigation of the  
Antarctic Red Alga Delisea pulchra 
Santhisree Nandiraju 
ABSTRACT 
 
Our interest in the red alga Delisea pulchra (= D. fimbriata)  (Greville) Montagne 1844 
(Rhodophyceae, Bonnemaisoniales, Bonnemaisoniaceae) was stimulated by its activity in 
the bioassays done at Wyeth Pharmaceuticals. Halogenated compounds from D. pulchra 
interfere with Gram-negative bacterial signaling systems, affect the growth of Gram-
positive bacteria, inhibit quorum sensing and swarming motility of marine bacteria 
(inhibit bacterial communication). They also inhibit surface colonization in marine 
bacteria and exhibit antifouling properties against barnacle larvae and macroalgal 
gametes.2 
Chemical investigation of D. pulchra collected near Palmer Station, Antarctica yielded 
three new dimeric halogenated furanones, pulchralides A-C (41-43), along with 
previously reported fimbrolide (21), Acetoxyfimbrolide (22), hydroxyfimbrolide (23) and 
halogenated ketone 40. The reported Compounds were characterized by comparison of 
their 1H and 13C NMR data with that previously published. Pulchralide A-C were 
characterized by both 1D (1H NMR, 13C NMR, DEPT, 1H-1H COSY) and 2D (gHMQC, 
gHMBC) NMR techniques, supported by HREIMS/HRESIMS data. The absolute 
stereochemistry of Pulchralide A was determined by a single crystal X-ray analysis. 
 xi 
 
Significant antimicrobial activity was observed in acetoxyfimbrolide (22) and 
hydroxyfimbrolide (23), where as pulcharlide A (41) and fimbrolide (21) were weakly 
active. 
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Chapter 1. INTRODUCTION 
 
 
 
 
1.1. Marine Natural Products 
 
     If indeed it is true that all life originated in the oceans, some organisms remained in 
the sea and others escaped onto the land. All have captured our imagination and now in a 
retro-evolutionary sense, chemists are turning their gaze back from land to their watery 
origins. This has become possible with the advent of scuba diving equipment and deep 
sea submissible collection facilities. The recent chromatographic techniques and the 
wide-spread use of high-field Nuclear Magnetic Resonance (NMR) spectrometers have 
meant that the complete structural elucidation is now possible on small amounts of 
material.  Because of these developments chemists have all found excitement and 
adventure in the discovery of secrets of organisms hidden beneath the sea.1 The oceans 
cover more than 70% of the earth’s surface and the origin of all forms of life is supposed 
to have occurred in the sea.2 Thus it is fair enough to conclude that the biodiversity of the 
sea could be far greater than any other terrestrial ecosystem. Evidence coming from 
recent research on marine ecosystems like the deep sea floor and the coral reefs does 
affirm it suggesting that their biodiversity is much higher than that of tropical rain forests, 
a terrestrial ecosystem renown for its enormous biodiversity.3  
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     Marine natural products are of enormous importance to chemists and pharmacologists, 
who are keen to discover biologically active lead molecules. Marine natural products 
chemistry has evolved from being the source of a handful of chemical curiosities to one 
of the most productive areas of natural products research.1,4-9 The advent of sophisticated 
chromatographic techniques such as High Performance Liquid Chromatography (HPLC), 
Medium Pressure Liquid Chromatography (MPLC), Counter Current Chromatography 
(CCC) and gel filtration, high-field NMR techniques such as Heteronuclear Multiple 
Bond Correlation (HMBC), Heteronuclear Multiple Quantum Correlation (HMQC), 
Correlation Spectroscopy (COSY) and Nuclear Overhauser Enhancement Spectroscopy 
(NOESY) and mass spectrometric techniques coupled with X-ray crystallography have 
led to the  structural elucidation of substantially more complex and diverse natural 
products. This has led to an enhanced interest in the isolation of biologically active 
natural products. Marine organisms have provided natural product chemists with a rich 
source of unusual secondary metabolites.10 It is the novelty and complexity of the 
compounds discovered from marine sources that assures the success of research in this 
area.  There are many marine natural products that have no counterparts in the terrestrial 
world. Oceans are the reservoirs of many complex and unusual secondary metabolites. 
One of the most striking aspects of the field is its interdisciplinary nature; marine natural 
products chemists routinely collaborate with industrial pharmacologists, with marine 
biologists and ecologists whose interest and involvement is essential for meaningful 
progress in the field. 
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Many marine organisms are soft bodied and move slowly whereas some of them have a 
sedentary life style. Moreover, some of them do not have physical armaments like hard 
external shells or spicules.  Such organisms need to defend themselves from predators, as 
they are vulnerable to predation and competition. Many marine invertebrates such as 
corals, sponges and ascidians (tunicates) use highly evolved chemical compounds for 
purposes such as reproduction, communication, and protection against predation, 
infection, and competition.11  These bioactive chemical compounds may have antibiotic, 
anti-inflammatory, antiviral, cytotoxic, antitumor or antifungal properties. Some of these 
marine organisms have the ability to synthesize their own defensive secondary metabolite 
chemicals via de novo biosynthesis. Other organisms have been found to derive their 
defensive chemicals by a symbiotic relationship or simply from their dietary sources.12 
With great biodiversity in the marine realm, marine organisms produce a wide array of 
secondary metabolites with broad structural diversity.12,13 Therefore, the likelihood of 
finding a bioactive molecule that would be a potential remedy to dreaded diseases like 
cancer or AIDS, from the marine realm is far greater. Interest on the part of chemists has 
been two fold: natural product chemists have probed marine organisms as a source of 
new and unusual molecules, while synthetic chemists have followed by targeting these 
novel structures for development of new analogues and new synthetic methodologies and 
strategies.14,15 More recent studies of marine organisms have focused on their potential 
applications, particularly to the treatment of human diseases and control of agricultural 
pests.16 The original literature that has amassed over the years has been reviewed 
topically by Scheuer.5-9,15,17-20 The task of tracking and cataloging the steady stream of 
fascinating new structures has been done by John Faulkner in an annual survey.10 More 
natural products have been reported from sponges than from any other marine 
invertebrate phylum and many of the most promising pharmaceuticals and agents for cell 
biological research were isolated from sponges.21 The first isolation of a secondary 
metabolite from a marine organism was tyrian purple (6,6’-dibromoindigotin) (1) from a 
marine mollusk,1,22  identified in 1901. Tyrian purple was also the first marine natural 
product to be used for commercial applications. 
N
H
H
N
O
Br
Br
O  
Tyrian purple (1) 
 
     In the last few decades attention of many natural product drug discovery programs has 
been focused on the oceans and several drug candidates coming from different phyla of 
marine organisms have progressed into advanced phases of clinical trials.23 Metabolites 
of the phylum porifera account for almost 50% of the natural products reported from 
marine invertebrates.13 An unusual acetylinic fatty acid derivative taurospongin A (2) was 
isolated from an Okinawan sponge, Hippospongia sp. which inhibited both DNA 
polymerase β and HIV reverse transcriptase enzymes.24
HO3S NH
O O
O
O
O
(CH2)13
 
Taurospongin A (2) 
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     Discodermalide (3), a polyketide isolated from marine sponge Discodermia dissolute, 
was found to be a potent antitumor agent.25 It induces tublin polymerization similar to 
taxol. Structure-activity studies of discodermalide26 resulted in synthetic analogues and 
derivates, which showed greater promise and versatility than taxol, a current anticancer 
drug derived from Pacific yew tree Taxus bravifolia.27   
O
OH
OH
HO
OH CONH2O
 
Discodermalide (3) 
 
     Papuamine (4), an antifungal pentacyclic alkaloid was isolated from a thin, red 
encrusting sponge Haliclona sp. Papuamine is formally derivable from a C22 unbranched 
hydrocarbon and 1,3-diaminopropane and inhibits the growth of the fungus Trichophyton 
mentagrophytes.28
H
N
H
N
H H
HH
 
Papuamine (4) 
 
     Soft corals also provide an excellent source for bioactive marine natural products. 
Eleutherobin (5), a novel natural product isolated from an Indopacific marine soft coral is 
believed to be as potent as taxol.29 It inhibits microtubule depolymerization and thereby 
prevents division of cancer cells, which is the same mechanism of action as taxol.30
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HH
O
O
O
O
O
AcO
OH
OH
N
NO
 
Eleutherobin (5) 
     Marine prostaglandins, first discovered in a gorgonian31 have been isolated from other 
invertebrates and from red algae. Punaglandins,32 halogenated antitumor eicosanoids, 
were isolated from the octocoral Telesto riisei. Punaglandin 3 (6) is characterized by C-
12 oxygen and an unprecedented C-10 chlorine group and inhibits L1210 leukemia cell 
proliferation with an IC50 value of 0.02 µg/mL.32,33  
O
O
Cl
OAc
OAc O
HO  
Punaglandin 3 (6) 
 
     Ecteinascidins, isolated from the colonial ascidian Ecteinascidia turbinata were not 
only cytotoxic but also found to be DNA interactive agents.34,35  Ecteinascidin 743 (7) 
was very selective against breast cancer and melanoma  and has advanced into phase II 
clinical trials.36
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Ecteinascdin 743 (7) 
 
 
     Of the alkaloid metabolites reported from tunicates, eudistomins are the most 
interesting from a chemical point of view. The oxathiazepine-bearing eudistomin C (8), 
has been isolated from a colonial tunicate Eudistoma olivaceum.37 The oxathiazepine-
bearing eudistomins are potent antiviral agents.37
N
Br
HO
S
O
H2N
NH
 
Eudistomin C (8) 
 
     Dolastatin 10 (9) isolated from the sea hare Dolabella auricularia, is a short 
polypeptide containing unique amino acids and showing microtubulin stabilization 
properties.38  Dolastatins  have also been isolated from a nudibranch and a 
cyanobacterium. Dolastatin analogues are in clinical trials.39 
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Dolastatin 10 (9) 
 
     Isolated from the bryozoan Bugula neritina, bryostatin 1 (10) is one of the first drug 
candidates from the ocean to proceed into clinical trial stages.40  Bryostatin 1, a complex 
polyketide which inhibits protein kinase C and thereby prevents cancer, is in Phase II 
clinical trails.41
O
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Bryostatin 1 (10) 
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1.2. Antarctic Ecology and Chemistry 
 
     A few decades ago it was conventional wisdom that competition and predation among 
the marine species are most intense in tropical waters12 and as a result the chemical 
ecology of the marine organisms dwelling in the tropical waters received more attention 
in drug discovery programs.12 However, recent research on the organisms of the Antarctic 
benthos suggests that they are indeed threatened by invertebrate predators and 
competitors such that they have evolved chemical defenses to ward them off.12 The 
physical environment on the Antarctic benthos has been stable for more than 20 million 
years42, a period sufficient for the biologically accommodated ecosystem whereby 
predation and competition are dominant forces determining the species composition and 
distribution. This would have given ample time to facilitate the evolution of the 
biogenetic pathways leading to bioactive secondary metabolites.13 Also; the continent has 
been isolated from its lower latitude neighbors even longer. The factors such as physical 
stability and isolation are important for genetic divergence and this has resulted in high 
levels of endemism in Antarctica.13 An expedition undertaken to study the sea floor of 
McMurdo Sound Antarctica in 1980 revealed that the benthos under the ice is rich in 
marine life and is dominated by a dynamic community of sponges, soft corals, molluscs, 
tunicates and echinoderms.42  
 
 
 
     Many of these organisms are immobile and cannot move to less densely populated 
regions if the area they live in becomes over-grown with competitors. Hence, it is 
apparent that either these sessile organisms do not have predators or that they have some 
kind of a defense. Studies on bottom-dwellers of Antarctica showed that they do have 
many predators. These include swarms of the voracious Paramoera antractica, a one-
centimeter long crustacean resembling a shrimp, and dense populations of sea stars.12 It 
can be concluded that these organisms produce defensive chemicals to protect themselves 
from predators. Among chemical investigations done on Antarctic organisms to date, 
several bioactive molecules have been characterized. There are nearly 200 different 
secondary metabolites described from Antarctic organisms.13 Sponges are the dominant 
macro-invertebrates found on the Antarctic benthos. The sponge Dendrilla membranosa 
produces defensive chemicals membranolide (11) and 9,11-dihydrogracilin A (12) which 
showed mild activity against Bacillus subtilus.43,44  
COOMe
O
O
O
H
OAc
OAc
H
H
 
                     Membranolide (11)                           9,10-dihydrogracillin (12) 
 
     The Antarctic green sponge Latrunculia apicalis from McMurdo Sound has been 
shown to elaborate a series of iminoquinone pigments called discorhabdins typified by 
discorhabdin C (13).44,45 In addition to significant feeding deterrence activity they are 
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antibiotic and cytotoxic.46 Variolin A (14),  an unusual cytotoxic alkaloid,  has been 
isolated from a bright red sponge Kirkpartrickia variolosa.47
H
N
O
Br Br
O
+NH
H
N
N
N
N
NN
O-
NH2
HO
NH2
+
+
 
                             Discorhabdin C (13)                               Variolin A (14) 
 
     Leucetta leptorhapsis, the Antarctic rubber sponge, produces the acetogenin, 
rhapsamine (15), which bears the unusual 1,3-diaminoglycerol group.  In addition to 
cytotoxicity, rhapsamine has antipredatory activity.48
H2N
H
N
OH
N
H
H2N
OH
 
Rhapsamine (15) 
 
     Sponges of McMurdo Sound Antarctica are subject to predation by sea stars, and it is 
considered to be a dominant ecological factor that might drive the production of defense 
chemicals.  The bright yellow Antarctic sponge, Isodictiya erinacea, which lacks physical 
defenses (spicules and mucus) is one of the several chemically defended sponges in the 
region. Erebusinone (16), a yellow pigment found in the sponge, showed molt inhibition 
in crustaceans,49 a possible strategy of chemical defense.  
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Further investigation of I. erinacea showed the presence of purines and a nucleoside 
metabolite erinacin (17), which showed cytotoxicity.50 
 
N
H
O
OH
O
N
N NH
H
N
NH
ONH2
HO
O
 
                         Erebusinone (16)                                        Erinacin (17) 
     The pteropod Cliona antarctica is a shell-less pelagic mollusc which blooms in each 
austral summer in McMurdo Sound and has an intriguing relationship with the amphipod 
Hyperiella dilatata, where the amphipod positions the mollusc on its dorsum and defends 
itself from predatory fish utilizing the defense chemicals of the mollusc. A bioassay 
guided fractionation of the mollusc afforded the feeding deterrent pteroenone (18).51 
 
O OH
 
Pteroenone (18) 
 
 
     Perknaster fuscus is the major predator of sponges, regulating the abundance of the 
potentially space-dominating sponge Mycale acerata.42 Aqueous extracts from body wall 
tissues of P. fuscus showed cytotoxic activity in a fertilized echinoderm egg assay 
employing the Antarctic sea urchin Sterechinus neumayeri.52 The cytotoxicity likely 
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results from a novel tetrahydroisoquinoline alkaloid, fuscusine (19) which has been 
isolated from the tissues of body wall of P. fuscus.53 
 
NH
N
H
NH2
NH
HO
OH
 
Fuscusine (19) 
 
     The Antarctic nudibranch Tritoniella belli sequesters the secondary metabolite chimyl 
alcohol (20) from its diet, an Antarctic soft coral Clavularia frankliniana. Chimyl alcohol 
(20) was found to cause feeding inhibition in the omnivorous Antarctic sea star 
Odontaster validus.54  
HO O
(CH2)15CH3
OH
 
Chimyl alcohol (20) 
 
      The benthos of Antarctica has many organisms that need to be investigated for their 
chemistry and bioactivity.  In addition there are many parts of underwater Antarctic 
Peninsula that have never been explored. Considering the already evident significant 
variations in chemistry of the species that have been studied from the regions of 
McMurdo Sound and Palmer Station, a comprehensive chemical and bioactivity 
investigation of these species in various parts of Antarctica is of considerable interest. 
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Chapter 2. CHEMICAL INVESTIGATION OF THE ANTARCTIC RED ALGA 
 
 DELISEA PULCHRA 
 
 
 
2.1. Introduction 
 
 
     Marine macroalgae have been a remarkable source of chemical diversity, responsible 
for roughly 20% of compounds reported from marine sources.       Compounds from 
macroalgae are characteristic of their biological origin: red algae (Rhodophyceae) 
produce largely polyhalogenated monoterpenes, sesquiterpenes and acetogenins. Brown 
algae (Phaeophyceae) produce primarily diterpenes, but are also rich in phlorotannins and 
known for their prenylated quinones or hydroquinones, and green algae (Chlorophyceae) 
produce sesqui- and diterpenes and are known for their 1,4-dialdehydes.  
10,55,56
10,55,56 Marine red 
alga from the family Bonnemaisoniaceae have been shown to produce a wide range of 
halogenated metabolites,57 including butenones,58 pyranones,59 acetones, acrylic and 
acetic acids,60 octenones61 and from the genus, Delisea halogenated furanones.62 Delisea 
species are somewhat special when compared to many other algal species, in their 
apparent ability to stave off colonization by common epiphytes and also to be a food 
source which is generally not preferred by obligate herbivores.63  
 
      
     Delisea pulchra (=D. fimbriata) (Figure 1) (Greville) Montagne 1844 (Rhodophyceae, 
Bonnemaisoniales, Bonnemaisoniaceae) has been the focus of prior ecological and 
bioactivity studies.62 Halogenated compounds from D. pulchra interfere with Gram-
negative bacteria signaling systems, affect the growth of Gram-positive bacteria, inhibit 
quorum sensing and swarming motility of marine bacteria (inhibit bacterial 
communication). They also inhibit surface colonization in marine bacteria and exhibit 
antifouling properties against barnacle larvae and macroalgal gametes.63 
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Figure1. The Antarctic red alga Delisea pulchra (photograph courtesy: www.seaweed.ie; 
© John Huisman). 
 
 
A series of 2 (5H)-furanones, with structures 21 through 39 were isolated from D. 
pulchra collected over a wide geographic range.64 
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2.2. Extraction and Isolation of Secondary Metabolites 
 
     The collection and extraction of Delisea pulchra from Palmer Station, Antarctica in 
2001, yielded seven compounds, fimbrolide (21), acetoxyfimbrolide (22), 
hydroxyfimbrolide (23), halogenated ketone  40, pulchralide A (41), pulchralide B (42) 
and pulchralide C (43). D. pulchra (800 g wet) was extracted thrice with 1:1 
dichloromethane/methanol to yield 3.5 g of lipophilic extract and then extracted thrice 
with 1:1 methanol/water to yield 18.8 g of hydrophilic extract (Scheme 1). The lipophilic 
extract showed a 12 mm zone of inhibition against two Gram-positive bacteria, 
methicillin-sensitive and -resisitant Staphylococcus aureus (MRSA and MSSA 
respectively) and an 8 mm zone of inhibition against a fungus Candida albicans. The 
lipophilic extract was subjected to silica gel flash column chromatography to yield 5 
fractions. Fimbrolide (10 mg, 0.0012%) was obtained from Normal Phase (NP) HPLC of 
fraction 1 (1:99 EtOAc/hexane), halogenated ketone 40  (40 mg, 0.005%) was obtained 
from NP HPLC of fraction 2 (5:95 EtoAc/Hexane), acetoxyfimbrolide (13 mg, 0.0016%) 
and two new compounds, pulchralide B (3 mg, 0.00037%) and C (2.5 mg, 0.0003%), 
were obtained from NP HPLC of fraction 3 (1:9, 12:88, 15:75 EtOAc/hexane). Another 
new compound, pulchralide A (10 mg, 0.0012%), and hydroxyfimbrolide (14 mg, 
0.0017%) were obtained from the NP HPLC of fraction 5 (2:8 EtOAc/hexane). 
 
 
 
Scheme 1.  Isolation of fimbrolide (21), acetoxyfimbrolide (22), hydroxyfimbrolide 
(23), halogenated ketone 40, pulchralide A (41), pulchralide B (42) and pulchralide 
C (43). 
 
 
     Delisea pulchra
  800 g (Frozen and wet)
1. Extracted with 3X 1:1 CH2Cl2:MeOH, 24 hr each
2. Combine supernatents, filter and concentrate in 
vacuo
Lipophilic extract
(3.5 g)
   51.5 mg                 50 mg                         500 mg                  384 mg                             2.6 g
NP silica gel coulmn
2.5 cm X 45 cm gradient elution
from hexane to EtOAc
Halogentated
Ketone 40
Fimbrolide (21)
NP HPLC
EtOAc/Hexanes
(1:99)
NP HPLC 
EtOAc/Hexanes
(5:95)
NP HPLC
EtOAc/hexanes
(10:95)
NP HPLC
 EtOAc/hexanes
(15:85)
Fraction 1             Fraction 2                  Fraction 3             Fraction 4                       Fraction 5
 Acetoxy-
fimbrolide 
    (22)
Pulchralide B
     (42)
Pulchralide C
     (43)
Pulchralide A
     (41)
Hydroxy-
fimbrolide
   (23)
Hydrophilic extract 
       (18.8 g)
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2.3. Characterization of Fimbrolide (21) 
 
     Compound 21 was the first fraction to elute from NP HPLC of fraction 1 (Scheme 1). 
Compound 21 was found to be identical with fimbrolide65 from the data discussed below. 
Fimbrolide (21) was obtained as colorless oil and was assigned a molecular formula of 
C9H10O2Br2 deduced from LREIMS m/z 312/310/308 (1:2:1). The 1H NMR spectrum 
(Figure 2) of fimbrolide in CDCl3 showed signals at δ 6.27 (1H, s) corresponding to an 
olefinic hydrogen and to an aliphatic chain at δ 2.41 (2H, t, J = 7.5 Hz), 1.35 (4H, m) and 
0.93 (3H, t, J = 6.5 Hz).  
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Figure 2. 1H NMR spectrum of fimbrolide (21) (500 MHz, CDCl3). 
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     The 13C NMR spectrum (Figure 3) of fimbrolide (21) showed signals corresponding to 
a lactone carbonyl at δ 166.3, a tetrasubstituted double bond at δ 150.2 and 134.1, a 
trisubstituted, enolic double bond at δ 130.0 and 91.1 and other signals corresponding to 
an aliphatic chain at δ 29.2, 25.2, 22.6 and 13.9. The infrared spectrum gave evidence for 
a carbonyl at 1787 cm-1. The UV λmax of 292 nm (log ε 4.92) suggested the presence of a 
conjugated ketone.     
 
Figure 3. 13C NMR spectrum of fimbrolide (21) (125 MHz, CDCl3) 
The structure of fimbrolide (21) was established by comparing the 1H NMR, 13C NMR, 
IR, UV, mass spectra and optical rotation values with those of the previously reported 
compound65. For fimbrolide (Figure 4), the reported chemical shifts of the olefinic 
hydrogen established the configuration of the exocyclic double bond as Z in our isolate.65 
 20
OBr
O
H
Br
O
Br
O
Br
H
6.24
6.56  
Figure 4. 1H NMR chemical shift values of H-6 in Z and E isomers of  
fimbrolide (21).65
 
     Fimbrolide (21) was weakly active in antimicrobial assays, with 7 mm hazy zone of 
inhibition (all antimicrobial assays done at 200µ g/spot) MRSA and MSSA (no inhibition 
of other microbes tested).   
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2.4. Characterization of Acetoxyfimbrolide (22) 
 
     Compound 22 was eluted from the NP HPLC of fraction 3 as yellow oil (Scheme 1). 
Compound 22 was found to be identical with acetoxyfimbrolide66, from the spectral and 
physical data discussed below. Acetoxyfimbrolide (22) was the major halogenated 
metabolite from our collections of Delisea pulchra. LREIMS m/z 370/368/366 (1:2:1) 
indicated a molecular formula of C11H12Br2O4. The 1H NMR spectrum of 
acetoxyfimbrolide (Figure 5), showed signals at δ 2.09 (3H, s) and δ 5.52 (1H, dd, J = 
7.2, 7.0 Hz), indicative of an acetoxyl group on an aliphatic chain.  
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Figure 5. 1H NMR spectrum of acetoxyfimbrolide (22) (250 MHz, CDCl3). 
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     The 13C NMR spectrum (Figure 6) of acetoxyfimbrolide (22) also indicated the 
presence of an acetate function (δ 170.0 and 20.4) and an α-β-unsaturated γ-lactone (δ 
163.6, 149.6 and 131.2). From the  comparison of 1H NMR and 13C NMR spectra to 
published spectra66 it can be concluded that acetoxyfimbrolide (Figure 7) differs from 
fimbrolide (21) only in the acetoxy substitution on the butyl chain.  
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Figure 6. 13C NMR spectrum of acetoxyfimbrolide (22) (62.5 MHz, CDCl3). 
 
  
     The 1H NMR spectrum of acetoxyfimbrolide (22) showed the bromomethine (δ 6.38, 
1H, s) at a higher field than (E)-acetoxyfimbrolide,67 indicating that the exocylic double 
bond has a Z configuration. The absolute configuration of acetoxyfimbrolide, previously 
reported from X-ray analysis as 1'R and 5 Z was found to match with our isolate because 
of similar optical rotation value of [α]25 D +15.0 (c, 0.4 CHCl3).68
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Figure 7. Acetoxyfimbrolide (22). 
 
 
     The IR spectrum of acetoxyfimbrolide (22) showed νmax of 1788 cm-1(acetate 
carbonyl) and 1736 cm-1 (lactone carbonyl). Analysis of the UV spectrum, showed λmax 
291 nm (log ε 4.94) which is similar to the absorption properties of α,β-unsaturated γ-
lactones compounds.66   
     From the Palmer Station collections of Delisea pulchra antimicrobial activity was 
greatest in acetoxyfimbrolide, which showed potent activity with 25 and 24 mm zones of 
inhibition against MRSA and MSSA respectively, a 16 mm zone toward vancomycin-
resistant Enterococci faecium (VREF) and a 17 mm zone using Candida albicans. It was 
modestly active against permeablized (a mutant strain with increased permeability to 
large molecular weight compounds) Escherichia coli (9 mm hazy zone). 
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2.5. Characterization of Hydroxyfimbrolide (23) 
 
     The most polar compound isolated in this study was compound 23, obtained from NP 
HPLC of fraction 5 (Scheme 1) as yellow oil. Compound 23 showed physical and 
spectral data similar to the reported hydroxyfimbrolide,65 which is discussed below. 
LREIMS of hydroxyfimbrolide (23) m/z 328/326/ 324 (1:2:1) supported a molecular 
formula of C9H10O3Br2. The 1H and 13C NMR resonances of hydroxyfimbrolide were 
very similar to those of acetoxyfimbrolide (22), in particular with reference to the 
furanone ring and the butyl chain, indicating a closely related structure. The 1H NMR 
spectrum (Figure 8) of hydroxyfimbrolide showed a doublet at a δ 2.54 (1H, d, J = 9.5 
Hz) probably resulting from an unusual coupling of a hydroxyl proton (D2O 
exchangeable) to the hydroxy substituted proton. This suggests the presence of a 
hydroxyl substitution on the butyl chain in hydroxyfimbrolide compared to the acetoxy 
substitution in acetoxyfimbrolide. Comparison of the 1H and 13C NMR spectral (Figure 8 
and 9) data set to that reported65 for hydroxyl fimbrolide (Figure 10) confirmed their 
identity. The IR spectrum showed the presence of a carbonyl group at 1736 nm-1 (γ-
lactone) and a broad hydroxyl group at 3457 nm-1. The UV λmax of 292 nm (log ε 4.90) 
demanded that the γ-lactone function was doubly conjugated.  
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Figure 8. 1H NMR spectrum of hydroxyfimbrolide (23) (250 MHz, CDCl3). 
 
 
Figure 9. 13C NMR spectrum of hydroxylfimbrolide (23) (125 MHz, CDCl3). 
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     The assignment of a Z configuration of the double bond in hydroxyfimbrolide (23) 
was established by consideration of the chemical shift of H-6, which was upfield at δ 6.38 
(1H, s). Hydroxyfimbrolide (23) was found to be 1'R and 5Z from its [α]25 D +15.0 (c, 0.4 
CHCl3), which matched the previously reported value.68
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            Figure 10.  Hydroxyfimbrolide (23). 
 
 
           Hydroxyfimbrolide displayed large zones of inhibition with Gram-positive 
bacteria (23 mm and 23 mm for MRSA and MSSA respectively), 14mm for VREF and a 
25 mm zone against Candida albicans. It was modestly active against Escherichia coli (9 
mm hazy zone).  
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2.6. Characterization of Halogenated Ketone 40  
 
     NP HPLC of fraction 2 resulted in the isolation of compound 40 (40 mg, 0.005%) as a 
colorless oil. Compound 40 was found to be identical with the reported69 Halogenated 
ketone from the physical and spectral analysis, which is discussed below. Analysis of 
mass spectrum showed a molecular formula of C8H11Br3O deduced from LREIMS m/z 
304/306/308/310 (1:2:2:1). The 1H NMR spectrum (Figure 11) of halogenated ketone 40 
showed a methylene triplet at δ 2.79 (2H, t, J = 7.5 Hz), an aliphatic envelope at δ 1.70-
1.33 (6H) and a methyl triplet at δ 0.94 (3H, t, J = 7.0 Hz).  
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Figure 11. 1H NMR spectrum of halogenated ketone 40 (250 MHz, CDCl3). 
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     A signal at δ 197.4 in the 13C NMR spectrum (Figure 12) of Halogenated ketone 40 
has a ketone function and signals at δ 91.2 and 121.9 are indicative of a shielded, 
tetrasubstituted olefin. A pentyl chain is evident from 13C NMR resonances at δ 40.7, 
31.1, 23.2, 22.4 and 13.9.The infrared spectrum supports the assignment of a carbonyl at 
1715 cm-1. The UV spectrum showed λmax of 220 nm (log ε 4.84) and 283 nm (log ε 
4.03). 
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Figure 12. 13C NMR spectrum of halogenated ketone 40 (62.5 MHz, CDCl3). 
 
 
     
 
 
 
 29
 Halogenated ketone 40 (Figure 13) was identified by the matching of physical and 
spectral data set with those of the previously reported compound.69 
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Figure 13.  Halogenated ketone 40. 
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2.7. Characterization of Pulchralide A (41) 
 
    A second compound, 41, obtained from the polar fraction 5 (Scheme 1) was found to 
be a new compound from its structural elucidation discussed below. Compound 41  was 
named after the species name of  the red alga Delisea pulchra as Pulchralide A. 
Pulchralide A (41), molecular formula of C22H24Br4O8 (HREIMS m/z 734.8260. requires 
m/z 734.8262), was crystallized from ethanol as colorless needles. Pulchralide A 
displayed the characteristic aliphatic 1H NMR signals (Figure 14) similar to those 
observed in acetoxyfimbrolide, including the olefinic hydrogen at δ 5.18 (1H, s), an 
acetoxy substituted methine at δ 5.52 (dd, 1H, J = 6.5, 8.0 Hz), an acetate methyl at δ 
2.11 (3H, s), signals corresponding to the butyl chain at δ 1.91, 1.36 and 0.96 (3H, t, J = 
7.5 Hz). But the olefinic proton is at higher field than in pulchralide A than in 
acetoxyfimbrolide, where it resonates at δ 6.38. 
     The 13C NMR spectrum (Figure 15) of pulchralide A (41) significantly differed from 
acetoxyfimbrolide (22). In particular, only two 13C signals were observed in the olefinic 
region of pulchralide A, unlike four olefinic signals found in acetoxyfimbrolide (δ 149.6, 
131.2, 130.4, 93.3). It lacked the trisubstituted enolic double bond signals of 
acetoxyfimbrolide at δ 130.4. The heteroatom-bearing region suggested there were three 
heteroatom-bearing sp3 carbons. The complete 1H NMR and 13C NMR assignments can 
be found in Table 1. 
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Figure 11. 1H NMR spectrum of pulchralide A (41) (500 MHz, CDCl3). 
 
 
 
Figure 15. 13C NMR spectrum of pulchralide A (41) (125 MHz, CDCl3). 
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     The 135° Distortionless Enhancement by Polarization Transfer (DEPT-135) spectrum 
of pulchralide A (41) (Figure 16) showed a methine at δ 39.5 suggesting the absence of 
an exocyclic double bond. It also showed the presence of the acetoxy bearing carbon at δ 
64.6 as a methine, two methylenes at δ 33.8 and 16.7 and two methyl groups at δ 20.9 
and 14.7.  
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Figure16. DEPT-135 spectrum of pulchralide A (41) (125 MHz, CDCl3). 
 
 
     The planar structure was established by 2D NMR techniques. In the 1H-1H Correlation 
Spectroscopy (COSY) spectrum (Figure 17) of pulchralide A (41), cross peaks were 
observed between H-1' and H-2', H-2' and H-3' and between H-3' and H-4' (Figure 18). 
Gradient Heteronuclear Multiple Quantum Correlation (gHMQC) spectrum (Figure 19) 
of pulchralide A showed the correlations of acetate substituted methine proton at δ 5.5 
with C-1' (δ 68.5) which suggested the substitution of acetoxy group at C-1' on the butyl 
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side chain. Cross peaks were also observed between H-6 (δ 5.18) and C-6 (δ 43.9), as 
well as the acetate methyl Me-8 (δ 2.11) and C-8 (δ 20.8).  
 
 
Figure 17. gCOSY spectrum of pulchralide A (41) (500 MHz, CDCl3). 
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Figure 18. 1H-1H COSY correlations of pulchralide A (41). 
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Figure 19. gHMQC spectrum of pulchralide A (41) (500MHz, CDCl3). 
 
     The significant correlations observed in gradient heteronuclear mutlitple bond 
correlation spectrum (gHMBC) spectrum (Figure 20) of pulchralide A (41) were between 
H-1' (δ 5.5) and C-2 to C-4 and C-8 of the lactone ring (Table 1). Correlations were also 
seen for H-6 to C-5 and C-6. Because gHMBC spectra show only two and three bond 
correlations (2JH,3JH, correlations), the correlation of H-6 to the C-6 (Figure 21) was the 
first clue that the metabolite was a dimer. The hypothesis that pulchralide A is a dimer 
was supported by mass spectral analysis which provided a molecular formula of 
C22H24Br4O8 (m/z 732/734/736/738 (1:4:6:4:1), HREIMS 734.8260, C22H240879Br381Br 
requires 734.8262). Thus pulchralide A appears to be a dimer of acetoxyfimbrolide (22) 
and has not been previously reported. 
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Figure 20.  gHMBC spectrum of pulchralide A (41) (500 MHz, CDCl3). 
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Figure 21. KEY HMBC correlations determined in pulchralide A (41). 
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Table 1. NMR data of pulchralide A (41) (CDCl3) (13C, 125 MHz; 1H, 500 MHz). 
Position                 1H (δ)                             13C (δ)                         gHMBC 
 
1'/1'a            5.52 (1H, dd, J = 6.5, 8.0 Hz)  68.5              C-7/7a, C-2/2a to C-4/4a,  
6/6a              5.18 (1H, s)                              43.9              C-6/6a, C-55a, C-4/4a 
8/8a              2.11 (3H, s)                              20.8              C-7/7a 
2'/2'a            1.91 (2H, m)                             33.8              C-1'/1'a, C-3'/3'a, C-3/3' 
3'/3'a            1.36 (2H, m)                             18.6              C-1'/1'a, C-4'/4'a 
4'/4'a            0.96 (3H, t, J = 7.5 Hz)            13.8              C-2'/C-2'a C-3'/3'a 
7/7a                   -                                         170.0 
2/2a                   -                                         164.9 
4/4a                   -                                         139.7 
3/3a                   -                                         134.5 
5/5a                   -                                           90.4  
 
     The crystallization of the pulchralide A (41) has led to the determination of the 
absolute stereochemistry of pulchralide A by a single crystal X-ray analysis performed by 
Dr. Mike Zaworotko at University of South Florida, Tampa. (Figure 22 and 23).  
 
Figure 22. Perspective view of X-ray crystal structure of pulchralide A (41). 
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Figure 23. Sterochemical assignments of pulchralide A (41). 
 
     To ensure that the pulchralide A (41) is not an artifact, especially of photochemical 
origin, acetoxyfimbrolide (22) (1 mg), dissolved in chloroform was irradiated with UV 
and visible light for 24 hrs each. 1H NMR spectra of the irradiated acetoxyfimbrolide did 
not show signs of dimer formation, supporting their biotic origin. Pulchralide A was 
modestly active in antimicrobial assays against MRSA and MSSA with 7 mm hazy zones 
of inhibition respectively.   
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2.8. Characterization of Pulchralide B (42) 
 
     Compound 42, obtained from the NP HPLC of fraction 3 (Scheme1) as white solid,  
was characterized as discussed below and found to be a new compound, which was 
named as pulchralide B. Pulchralide B (42) demonstrated many of the structural features 
of pulchralide A (41).  The 1H NMR spectrum (Figure 24) of pulchralide B lacked the 
acetoxymethine of  pulchralide A, and a new allylic methylene signal was found at δ 2.43 
(3H, t, J = 7.5 Hz), analogous to the allylic H-1’ of fimbrolide (21). The 13C NMR 
spectrum (Figure 25) of pulchralide B showed only two signals in the olefinic region, 
similar to pulchralide A, but did not show any signals indicative of an acetoxy group.  
 
Figure 24. 1H NMR spectrum of pulchralide B (42) (500 MHz CDCl3).  
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    The 13C NMR spectrum (Figure 25) of pulchralide B showed only two signals in the 
olefinic region, similar to pulchralide A, but did not show any signals indicative of an 
acetoxy group. The DEPT-135 spectrum (Figure 26) of pulchralide B showed one 
methine carbon at δ 44.1, one methyl of the butyl side chain at δ 13.9 and three 
methylenes at δ 29.0, 25.5, and 22.4.  
 
Figure 25. 13C NMR spectrum of pulchralide B (42) (125 MHz, CDCl3).  
 40
  
 4
4.
18
7
 2
9.
02
6
 2
5.
52
5
 2
2.
47
2
 1
3.
94
6
40 35 30 25 20 15 PPM
 
Figure 26. DEPT-135 spectrum of pulchralide B (42) (125 MHz CDCl3).  
 
 
The planar structure of pulchralide B (42) was deduced by interpretation of 2D NMR 
spectra. The gHMBC spectrum (Figure 27) of pulchralide B showed correlations of H-6 
with C-6 (Figure 28), similar to that in pulchralide A (41) revealing that pulchralide B is 
also a dimer.  The significant correlations (Table 2) observed in pulchralide B are the 
correlation of H-1' with C-3 indicating the attachment of the butyl side chain to the 
furanone ring. It also showed cross peaks between H-6 and C-5. Pulchralide B therefore 
is the symmetrical fimbrolide dimer, an assignment which is fully supported by the 
COSY and HMBC data sets and confirmed by mass spectral data, (m/z 
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615/617/619/621/623 (1:4:6:4:1), [M+ - H] , HREIMS 538.8894 [M+ - Br], 
C18H20O479Br281Br requires 538.8891). 
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Figure 27. gHMBC spectrum of   pulchralide B (42) (500 MHz, CDCl3). 
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Figure 28. Key HMBC correlations of pulchralide B (42). 
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Table 2. NMR data of pulchralide B (42) (CDCl3) (13C, 125 MHz; 1H, 500 MHz). 
Position               1H (δ)                                 13C (δ)                     gHMBC 
 
6/6a                5.20 (1H, s)                              44.1              C-6/6a, C-5/5a, C-4/4a 
1'/1'a              2.43 (1H, t, J = 7.5Hz)             29.0              C-3/3a, C-4/4a, C-2/2a 
2'/2'a              1.55 (2H, m)                             25.5              C-1'/1'a, C-3'/3'a, C-3/3'a 
3'/3'a              1.27 (2H, m)                             22.4              C-1'/1'a, C-4'/4'a. 
4'/4'a              0.93 (3H, t, J = 7.5Hz)             13.9              C-2'/2'a, C-3'/3'a 
2/2a                     -                                         167.4 
3/3a                     -                                         138.2 
4/4a                     -                                         137.1 
5/5a                     -                                           90.5 
_____________________________________________________________________        
 
     Of the two  possibilities that  pulchralide B (42) is either a  C2 dimer or meso dimer 
(Figure 29), the possibility that  it  is a meso dimer was ruled out because of its optical 
rotation of [α]25 D +4.26o (c 0.06, CHCl3). Hence pulchralide B is a C2 dimer. 
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Figure 29.  Pulchralide B C2 dimer and pulchralide B meso dimer. 
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2.9. Characterization of pulchralide C (43) 
 
      Compound 43, was the third compound, to be eluted from NP HPLC of fraction 3 
(Scheme1), whose structural determination as discussed below led to a new compound, 
named as pulchralide C.  Pulchralide C (43), was obtained as white solid and was found 
to have molecular formula of C20H22O679Br281Br2 (TOFMS m/z 700.8008, requires 
700.8007). The 1H NMR spectrum (Figure 30) of pulchralide A has signals related to 
both acetoxyfimbrolide (22) and fimbrolide (21). A single acetoxy methyl group at δ 2.09 
(3H, s) and an acetate substituted proton at δ 5.49 (1H, dd, J = 6.5, 8.0 Hz), evident in the 
1H NMR spectrum (Figure 30) confirm the resemblance to acetoxyfimbrolide while the 
signal at δ 2.38 (1H, t, J = 7.5 Hz) is reminiscent of fimbrolide. The doublets at δ 5.38 
(1H, d, J = 10.0 Hz) and at 5.13 (1H, d, J = 10.0 Hz) are indicative of the presence of 
olefinic bromo-methines.     The 13C NMR spectrum (Figure 31) of pulchralide C also 
showed peaks related to acetate group (δ 170.3 and δ 20.6), peaks characteristic of two 
lactone carbonyls (167.0, 165.3) and one acetoxy substitution at δ 68.8. The 1H and 13C 
NMR assignments are illustrated in Table 3.  
 
 
Figure 30.  1H NMR spectrum of pulchralide C (43) (500 MHz, CDCl3). 
 
 
 
Figure 31. 13C NMR spectrum of pulchralide C (43) (125 MHz CDCl3). 
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     The planar structure of pulchralide C (43) was established based on analysis of 2D 
NMR data. Analysis of the 1H-1H COSY spectrum (Figure 32) of pulchralide C (43) 
illustrated two bromomethine doublets, H-6 and H-6a, at δ 5.35 and 5.13 respectively, 
coupled with one another. This significant 1H-1H COSY correlation (Figure 33) supports 
the evidence that pulchralide C is an unsymmetrical dimer. The gHMBC spectrum 
established a two bond correlation between H-6 and C-6/C-6a supporting the assumption 
that pulchralide C is an unsymmetrical dimer. 
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Figure 32. 1H-1H COSY spectrum of pulchralide C (43) (500 MHz, CDCl3). 
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Figure 33. Key 1H-1H COSY correlation of pulchralide C (43). 
   
Table 3. NMR data of pulchralide C (43) (CDCl3) (13C, 125 MHz; 1H, 500 MHz) 
Position               1H (δ)                                    13C (δ)                        gHMBC 
 
1'                   5.49 (1H, dd, J = 6.5, 8.0 Hz)        68.8                      C-2, C-3, C-7 
6                    5.38 (1H, d, J = 10.0 Hz)               47.7                      C-5, C-6a                             
6a                  5.13 (1H, d, J = 10.0 Hz)               44.4                      C-5a, C-6 
1'a                 2.38 (1H, t, J = 7.5 Hz)                  33.4                      C-3, C-2'a. C-3'a 
8                    2.09 (3H, s)                                  170.3                      C-1' 
2'                   1.96 (2H, m)                                  28.9                       C-1a, C-3a, C-3 
2' a                1.81 (2H, m)                                  25.4                       C-1’a, C-3’a, C-3a 
3'                   1.34 (2H, m)                                  22.5                       C-2a, C-4a, C-1a               
3'a                 1.32 (2H, m)                                  18.7                       C-2’a, C-4’a, C-1’a 
4' &4' a         0.95 (6H, t, J =7.0 Hz)                  13.8                       C-3a/3’a, C-2a/2’a 
2                          -                                             167.0 
2a                        -                                             165.3 
4                          -                                             140.9 
4a                        -                                             139.6 
3                          -                                             135.5 
3a                        -                                             134.5 
5                          -                                               93.3 
5a                        -                                               88.1 
 
 
   The bromomethine protons couple with each other to form doublets with J = 10 Hz (δ 
5.35) and J = 10.0 Hz (δ 5.13). The trans coupling constants for protons of a four 
membered ring like cyclobutane is 2-10.67 This indicates that these two are trans to each 
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other Figure 34 illustrates the sterochemical assignments of pulchralide C (43) based on 
the above considerations.  
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Figure 34. stereochemical assignments of pulchralide C (43). 
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Chapter 3. DISCUSSION 
 
3.1. Biological Importance of Halogenated Metabolites of Delisea pulchra 
 
     Our interest in Delisea pulchra is due to the antimicrobial and antifungal activity of 
the organism we observed in the bioassay of the crude extract performed by Wyeth 
Pharmaceuticals, Pearl River, NY. Chemical investigation of D. pulchra resulted in the 
isolation of three new dimeric halogenated furanones pulchralide A-C (41-43) along with 
the previously reported fimbrolide (21), acetoxyfimbrolide (22), hydroxyfimbrolide (23) 
and halogenated ketone 40.  The structures of the new compounds were determined by 
1D, 2D NMR and mass spectral data. The absolute stereochemistry of pulchralide A (41) 
was established by single crystal X-ray crystallography. The structures of known 
compounds fimbrolide, acetoxy-fimbrolide, hydroxyfimbrolide and halogenated ketone 
40 were identified by comparing the physical and spectral data with those reported 
previously. The absolute stereochemistry of these compounds was already reported on the 
basis of chemical interconversions and X-ray and CD analyses.68 Fimbrolide, 
acetoxyfimbrolide, hydroxyfimbrolide were found have a Z configuration based on the 
chemical shifts of their respective hydrogen atoms.  
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     The bioassay data (Table 4) indicates that acetoxyfimbrolide (22) and 
hydroxyfimbrolide (23) have potent antimicrobial activity against two Gram-positive 
bacteria, MRSA and MSSA and against one Gram-negative bacterium, VREF and mild 
activity against the fungus Candida albicans. Acetoxyfimbrolide and hydroxyfimbrolide 
showed modest activity against permeablized Escherichia coli  
 
Table 4. Antimicrobial activity of pure compounds (100 µg/disk) using the disk          
diffusion assay (Zone of Inhibition in mm) 
_____________________________________________________________________ 
  
                                           MSSA      MRSA     VREF      Permeablized        Candida    
                                                                                          Escherichia coli      albicans    
_____________________________________________________________________ 
            
Acetoxyfimbrolide (22)         25            24            16               9:10H                 17  
        
Hydroxyfimbrolide (23)        23            23            14                9H                      25 
 
Fimbrolide (21)                     7H           7H             0                 0                          0 
 
Pulchralide A (41)                 7H          6:7H           0                 0                          0 
_____________________________________________________________________ 
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3.2. Origin of Halogenated Metabolites of Delisea pulchra 
  
     While several dimeric furanones have been described from the genus Delisea, two of 
which bear the central cyclobutane of the pulchralides, pulchralides A and C (41 and 43) 
are the first such dimers bearing the C-1’ acetoxy group. Pulchralides B (42) and C 
demonstrated many of the structural features of pulchralide A and C and pulchralide C is 
the only unsymmetrical member of the group. The cyclobutane dimers, pulchralide A 
could be derived from acetoxyfimbrolide (22), pulchralide B from hydroxyfimbrolide 
(23) and pulchralide C from both acetoxy-fimbrolide (22) and fimbrolide (21) by 
[Π2s+Π2s] cycloaddition reactions.62 Molecules which are formed by enzyme mediated 
reactions are almost invariably optically active.70 Examples of cyclobutane containing 
dimers are known.70 To ensure that the dimers described here were not artifacts, 
especially of photochemical origin, the solution of acetoxyfimbrolide was exposed to 
both UV and visible light for 24 hrs each with no discernable effects on the compound. 
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3.3. Ecological Importance of Halogenated Furanones of Delisea pulchra 
 
     Halogenated furanones from Delisea pulchra have various ecological and biological 
functions. The red macroalga (seaweed) D. pulchra is relatively free of surface 
colonization and the knowledge that it produced unusual secondary metabolites, 
halogenated furanones or fimbrolides prompted an in-depth investigation of the role of 
these metabolites as inhibitors of surface colonization. These compounds were 
encapsulated in vesicles in gland cells in the seaweed, providing a mechanism for 
delivery of the metabolites to the surface of the alga at concentrations which deter a wide 
range of prokaryote and eukaryote fouling organisms.71 Inhibition in these studies was by 
a non-toxic and non-growth inhibitory mechanism and the structural similarities between 
these algal metabolites and the bacterial signaling molecules, acylated homoserine 
lactones (AHL’s), led to the hypothesis that furanones act as specific antagonists of AHL 
regulatory systems.71 Furanones inhibit AHL-regulated phenotypes in a wide range of 
Gram-negative bacteria and their specific mode of action has now been demonstrated via 
both AHL phenotypic bioassays and targeted molecular systems.71 For example, 
furanones shut down AHL-regulated swarming in Serratia liquefaciens, biofilm 
development in Pseudomonas aeruginosa and bioluminescence in both wild-type Vibrio 
fischeri and luminescence constructs (e.g. in Escherichia coli backgrounds). The use of 
natural products such as furanones, which target specific bacterial signaling and 
regulatory systems, represents a promising approach to inhibition of biofilm.71
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     Barnacles cause corrosion and make ships heavier and harder to steer. Antifouling 
paints that contain tin or copper stop barnacles from attaching and leach metals into the 
sea and kill many non-target organisms. Antifouling furanones made by Delisea pulchra 
blocks bacterial communication systems and prevents bacterial biofilms from developing 
on its surface.63 This then stops barnacles from attaching. The seaweed metabolite may 
be used to replace the toxic chemicals in any environment that can be submerged. 
Research is now focused on further development of furanone based paints.63  The 
geographic variation of halogenated metabolites of D. pulchra has also been the subject 
of study.72 The large variability in concentrations of furanones, and the absence of any 
positive relationships between furanones, herbivores and epiphytes, suggest that 
quantitative variation in furanones in D. pulchra is not driven by population-level 
selection or induction, but is more likely to be a result of small-scale variation in 
environmental factors such as nutrients, light and genetic differences among individual 
plants.72 
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Chapter 4.  EXPERIMENTAL 
 
4.1. General Experimental Procedures.  
 
     Optical rotation was determined on a Rudolph Research Analytical AUTOPOL® IV 
with a sodium lamp (589 nm) and 0.5 dm cell at 25°c. Infrared spectra were obtained 
with Nicolet Avatar 320FT-IR in solid state. Ultraviolet-Visible experiments were 
measured on a Hewlett-Packard 8452A diode array UV/Vis spectrometer. 1H and 13C 
NMR, HMQC, HMBC and 1H-1H COSY spectra were obtained on either a Varian 500 
instrument operating at 500 MHz for 1H NMR and 125 MHz for 13C, or a Bruker Avance 
250 instrument operating at 250 MHz for 1H and 62.5 MHz for 13C. The 13C resonance 
multiplicities were determined by DEPT experiments. 1H-1H correlations were 
determined by using gCOSY experiment optimized coupling constant (JHH of 7 Hz). One 
bond connectivities (1JCH) of 1H-13C were determined via the 2D proton-detected gHSQC 
experiment. The interpulse delays were optimized for average 1JCH of 120 Hz. Two- or 
three-bond heteronuclear multiple-bonds (3JCH/ 2JCH) were recorded via the 2D proton 
detected gHMBC experiment optimized for a long range coupling constant (JCH of 7 Hz). 
High resolution mass spectra ESIMS, EI-MS and CIMS were obtained on Micro mass 
70-VSE spectrometer at the University of Illinois. HPLC was performed on Waters 510 
equipped with a Waters 490E programmable multiwavelength UV detector at 254 nm and 
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Shimadzu LC-8A equipped with a multisolvent delivery system connected to a Shimadzu 
SPD-10A UV-VIS tunable absorbance detector and/or an Alltech ELSD 2000 using a 
YMC-Pack® ODS-AQ C-18 analytical column, a Waters prepLC® (25 mm X 30 cm) C-
18 column for reversed phase, or Waters Sphereclone® (250 X 10 mm) for normal phase. 
Flash column chromatography was performed on EM Science normal phase Silica gel 60 
(200 – 400 mesh). Thin layer chromatography (TLC) was carried out using Whatman 
normal phase silica gel 60Å Partisil® K6F, reversed phase silica gel 60Å Partisil® 
KC18F, and CNF254s plates 0.25 mm thickness. There were visualized by spraying with 
5% phosphomolybdic acid in EtOH or heating and 2 % ninhydrin in BuOH/acetic acid 
(95:5).  
 X-ray Crystal Structure Determination: Single crystals suitable for x-ray 
crystallographic analysis were selected following examination under a microscope. 
Single-crystal x-ray diffraction data for the compounds were collected on a Bruker-AXS 
SMART APEX/CCD diffractometer using Moκα radiation (λ = 0.7107 Å). Diffracted 
data were corrected for Lorentz and polarization effects and for absorption using the 
SADABS73 program. The structure was solved by direct methods and the structure 
solution and refinement was based on |F|2. All non-hydrogen atoms were refined with 
anisotropic displacement parameters whereas hydrogen atoms were placed in calculated 
positions when possible and given isotropic U values 1.2 times that of the atom to which 
they are bonded. All crystallographic calculations were conducted with the SHELXTL 
v.6.174 program package.75
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4.2. Bioassay of Pure Compounds 
 
     Bioassays for the pure compounds were done at Wyeth Pharmaceuticals, Ford 
Hospital and in the Marine Natural Products Lab at University of South Florida, using 
standard disk diffusion method against two Gram-positive bacteria, Methicillin- resistant 
and -sensitive Staphylococcus aureus (MRSA and MSSA respectively) against two 
Gram-negative bacteria Vancomycin resistant Escherichia faecium (VREF) and 
permeablized Escherichia faecium and against one fungus Candida albicans. 
     Antibiotic assays: In vitro antimicrobial activities against methicillin-sensitive 
(MSSA, strain 375) and -resistant (MRSA, strain 310) Staphylococcus aureus, 
vancomycin-resistant Enterococci faecium (VREF, strain 379), E. coli (strain 442), E. 
coli imp (strain 389, a mutant strain with increased permeability to large molecular 
weight compounds) and Candida albicans (strain 54) were determined by agar diffusion 
method. Media used were Difco nutrient agar (pH 6.8) for S. aureus, LB (Luria-Bertani) 
agar for E. faecium and E. coli, and YM agar for C. albicans. Assay plates (9”x 9” 
Sumilon) were prepared by pouring 125 ml volume of agar medium (tempered at 50°C) 
inoculated with an overnight broth culture of the test organisms (adjusted to 
approximately 106 cells per ml). Sample concentrations of 200 µg in 10 µL aliquots were 
spotted onto agar surface and the plates were incubated at 37°C for 18h.75  
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The zones of growth inhibition were measured using a hand-held digital caliper. The 
zones of growth of inhibition were measured from the edge of the disk to the edge of the 
clear inhibition zone in mm, respectively. Control disks were treated with solvent alone 
(MeOH or CHCl3). The bioassay data for the pure compounds done at Wyeth 
Pharmaceuticals and at Marine natural products lab at University of South Florida can be 
found in Table 3. 
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4.3. Isolation of Secondary Metabolites from Delise pulchra 
 
     Plant Material. The algal material was collected at Palmer Station, Antarctica by 
scuba diving in November – December of 2001. Identifications were made by C. Amsler 
and K.B. Iken. A voucher specimen is available at the University of Alabama at 
Birmingham. The red alga Delisea pulchra is a reddish brown alga. 
     The red alga D. pulchra (800 g wet) was extracted thrice with 1:1 
dichloromethane/methanol to yield 3.5 g of lipophilic, and then extracted thrice with 1:1 
methanol/water to yield 18.8 g of hydrophilic extract. The lipophilic extract was 
subjected to silica gel flash column chromatography to yield 5 fractions. Fimbrolide (21) 
(10 mg, 0.0012%) was obtained from NP HPLC of fraction 1 (1:99 EtOAc/hexane), 
halogenated ketone 40  (40 mg, 0.005%) was obtained from NP HPLC of fraction 2 (5:95 
EtoAc/Hexane), acetoxyfimbrolide (22) (13 mg, 0.0016%) and two new compounds, 
pulchralide B (42) (3 mg, 0.00037%) and C (43) (2.5 mg, 0.0003%), were obtained from 
NP HPLC of fraction 3 (1:9, 12:88, 15:75 EtOAc/hexane). Another new compound, 
pulchralide A (41) (10 mg, 0.0012%), and hydroxyfimbrolide (23) (14 mg, 0.0017%) 
were obtained from the NP HPLC of fraction 5 (2:8 EtOAc/hexane). 
 
 
 
 
 
4.3.1. Spectral Data for Fimbrolide (21) 
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           Fimbrolide (21) 
 
Fimbrolide (21): 10 mg, 0.0012%, colorless oil; [α]25 D +4.5 (c, 0.9 CHCl3); IR vmax 
1787, 1213, 1042 cm-1; UV λmax  292 nm (log ε 4.92); 1H NMR (250 MHz, CDCl3) δ 
integration, multiplicity, J (Hz), assignment): 6.27 (1H, s, H-6), 2.41 (2H, t, 7.5, H-1’), 
1.35 (4H, m, H-2’, H-3’), 0.93 (3H, t,  6.5, H-4’); 13C NMR (125 MHz, CDCl3) δ 
(assignment) 166.3 (C, C-2), 150.2 (C, C-4), 134.1 (C, C-3),  130.0 (C, C-5), 91.1 (C, C-
6), 29.2 (CH, C-1’), 25.2 (CH2, C-2’), 22.6 (CH2, C-3’), 13.9 (CH3, C-4’); LREIMS m/z 
312/ 310/308 (1:2:1) for C9H10O2Br2. 
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4.3.2. Spectral Data for Acetoxy Fimbrolide (22) 
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              Acetoxyfimbrolide (22) 
 
Acetoxyfimbrolide (22): 13 mg, 0.0016%, yellow oil; [α]25D +47.0 (c, 1.5, CHCl3); IR 
vmax 1788, 1736, 1236, 1092 cm-1;  UV λmax  291 nm (log ε 4.94) ; 1H NMR (250 MHz, 
CDCl3) δ integration,  multiplicity, J (Hz), assignment): 6.38 (1H, s, H-6), 5.52 (1H, t, 
7.2, H-1’),   2.09 (3H, s, H-8), 1.83 (2H, m, H-2’), 1.35 (2H, m, H-3’) 0.94 (3H, t, 7.5, H-
4’); The 13C NMR (125 MHz, CDCl3) δ (multiplicity, assignment) 170.0 (C, C-7), 163.6 
(C, C-2), 149.6 (C, C-4), 131.2 (C, C-3), 130.0 (C, C-5), 93.3 (C,  C-6),  68.0 (CH, C-1’), 
33.5 (CH2, C-2’), 20.4 (CH3, C-8), 18.3 (CH2, C-3’), 13.5 (CH3, C-4’); LREIMS m/z 
370/368/366 (1:2:1) for C11H12Br2O4. 
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4.3.3. Spectral Data for Hydroxyfimbrolide (23) 
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            Hydroxyfimbrolide (23) 
 
 
Hydroxyfimbrolide (23): 14 mg, 0.0017%, yellow oil; [α]25 D +15.0 (c, 0.4 CHCl3); IR 
vmax 3457, 2959, 1736 cm-1; UV λmax  292nm (log 4.90); 1H NMR (250 MHz, CDCl3) δ 
integration, multiplicity,  J (Hz), assignment): 6.38 (1H, s, H-6), 4.58 (1H, dd, 6.7, 7.0, 
H-1’), 2.54 (1H, d, 9.5, OH), 1.84 (2H, m, H-2’), 1.42 (2H, m, H-3’), 0.96 (3H, t, 7.5, H-
4’). The 13C NMR (125 MHz, CDCl3) δ ( multiplicity, assignment); 165.5 (C, C-2), 149.9 
(C, C-4), 133.6 (C, C-3), 129.7 (C, C-5), 93.7 (C, C-6), 67.7 (CH, C-1’), 38.1 (CH2, C-
2’), 18.8 (CH2, C-3’), 13.9 (CH3, C-4’) ; LREIMS m/z of 328/326/324 (1:2:1) for 
C9H10O3Br2. 
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4.3.4. Spectral Data for Halogenated ketone 40  
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Halogenated ketone 40  
 
Halogenated ketone 40: 40 mg, 0.005%, colorless oil; IR vmax 1715, 1134,1085 cm-1; 
λmax 220 nm (log ε 4.84),  283 nm (log ε 4.03); 1H NMR (250 MHz, CDCl3) δ integration, 
multiplicity, J (Hz), assignment): 2.79 (t, 2H, 7.5, H-4), (1.70-1.33, 6H, H-5 to H-7), 0.94 
(3H, 7.0, H-8); 13C NMR (125 MHz, CDCl3) δ (multiplicity, assignment): 197.4 (C, C-3), 
91.2 (C, C-2), 121.9 (C, C-1), 40.7(CH2, C-4), 31.1( CH2, C-5), 23.2(CH2, C-6), 22.4 
(CH2, C-7), 13.9 (CH3, C-8);  LREIMS m/z 304/306/308/310 (1:2:2:1) for C8H11Br3O.  
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4.3.5. Spectral Data for Pulchralide A (41) 
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Pulchralide A (41) 
 
Pulchralide A (41): Colorless crystals; [α] 25 D +6.0 (c, 0.25, CHCl3); IR vmax 1747, 1740, 
2962, 1220 cm-1; UV λmax 252 nm (log ε 4.67); 1H NMR (500 MHz, CDCl3) δ integration, 
multiplicity J (Hz), assignment): 5.58 (2H, dd, 6.5, 7.5, H-1’, H-1’a), 5.17 (2H, s, H-6, H-
6a), 2.11 (6H, s, H-8, H-8a) 1.90 (4H, m, H-2’, H-2’a), 1.36 (4H, m, H-3’, H-3’a), 0.96 
(6H, t, 7.5, H-4’, H-4’a); 13C NMR (125MHz, CDCl3) δ (multiplicity, assignment): 170.0 
(C, C-7, C-7a), 164.9 (C, C-2, C-2a), 139.7 (C, C-4, C-4a), 134.5 (C, C-3, C-3a), 90.4 (C, 
C-5, C-5a), 68.5 (CH, C-1’, C-1’a), 43.9 (CH, C-6, C-6a) 33.8 (CH2, C-2’, C-2’a), 20.8 
(CH3, C-8, C-8a), 18.6 (CH2, C-3’, C-3’a), 13.8 (CH3, C-4, C-4’a); EIMS m/z 
732/734/736/738 (1:4:6:4:1);  HREIMS 734.8260 (C22H240879Br381Br requires 734.8262) 
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4.3.6. Spectral Data for Pulchralide B (42) 
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Pulchralide B (42) 
 
Pulchralide B (42): Colorless oil; [α] 25 D +4.2 (c 0.06, CHCl3); IR  vmax 1788, 2958 cm-1; 
UV λmax 245 nm (log ε 5.20); 1H NMR (500 MHz, CDCl3) δ (integration, multiplicity, J 
(Hz), assignment): 5.21 (2H, s, H-6, H-6a), 2.43 (2H, t, 7.5, H-1’, H-1’a), 1.56 (4H, m, 
H-2’, H-2’a), 1.35 (4H, m, H-3’, H-3’a), 0.94 (6H, t, 7.5, H-4’, H-4’a); 13C NMR 
(125MHz, CDCl3) δ (multiplicity, assignment): 167.4 (C, C-2, C-2a), 138.2  (C, C-4, C-
4a), 137.1 (C, C-3, C-3a), 90.5 (C, C-5, C-5a), 44.1 (CH, C-6, C-6a), 29.0 (CH2, C-1’, C-
1’a), 25.5 (CH2, C-2’, C-2’a), 22.4 (CH2, C-3’, C-3’a), 13.9 (CH3, C-4’, C-4’a); EIMS 
m/z 615/617/619/621/623(1:4:6:4:1), [M+ - H]; HREIMS 538.8894 ([M+ - Br], 
C18H20O479Br281Br requires 538.8891). 
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4.3.7. Spectral Data for Pulchralide C (43) 
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Pulchralide C (43) 
 
Pulchralide C (43): Colorless oil [α] 25 D +11.6 (c, 0.06, CHCl3); IR vmax 1786, 1741, 
2961, 1234 cm-1; UV λmax 246 nm (log ε 5.16); 1H NMR (500 MHz, CDCl3) δ 
(integration, multiplicity, J (Hz), assignment): 5.49 (1H, t, 7.5, H-1’), 5.35 (1H, d, 10.0, 
H-6), 5.13 (1H, d, 10.0, H-6a), 2.38 (1H, t, 7.5, H-1’a), 2.09 (3H, s, H-8), 1.89 (4H, m, H-
2’, H-2’a), 1.34 (4H, m, H-3’, H-3’a), 0.95 (6H, m, H-4’, H-4’a); 13C NMR (125MHz, 
CDCl3) δ (multiplicity, assignment): 170.3 (C, C-7), 167.0 (C, C-2), 165.3 (C, C-2a), 
140.9 (C, C-4), 139.7 (C, C-4a), 135.5 (C, C-3), 134.5 (C, C-3a), 93.3 (C, C-5), 88.1 (C, 
C-5a), 68.8 (CH, C-1’), 47.7 (CH, C-6), 44.4 (CH, C-6a), 33.4 (CH2, C-2’), 28.5 (CH2, C-
2’a), 25.4 (CH2, C-3’), 22.5 (CH2, C-3’a), 20.6 (CH3, C-8), 18.7 (CH2, C-1), 13.87 (CH3, 
C-4’), 13.80 (CH3,C-4’a); TOFMS m/z 696.8047/698.8026/ 700.8008/702.7991/704.7977 
(1:4:6:4:1, C20H22O679Br281Br2Na requires 700.8007). 
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Figure 35. IR spectrum of fimbrolide (21) 
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Figure 36. UV spectrum of fimbrolide (21) 
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 Figure 37. LREI Mass spectrum of fimbrolide (23) 
 
Figure 38. IR spectrum of acetoxyfimbrolide (22) 
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Figure 39. UV spectrum of acetoxyfimbrolide (22) 
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Figure 40. LREI Mass spectrum of Acetoxyfimbrolide (22) 
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Figure 41. IR spectrum of hydroxyfimbrolide (23) 
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Figure 42. UV spectrum of hydroxyfimbrolide (23) 
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 Figure 43. IR spectrum of halogenated ketone 40 
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Figure 44. UV spectrum of halogenated ketone 40 
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Figure 45.  LREI Mass spectrum of halogenated ketone 40 
 
 
 
 
Figure 46. IR spectrum of pulchralide A (41) 
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Figure 47. UV spectrum of pulchralide A (41) 
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Figure 48. LREI Mass spectrum of pulchralide A (41) 
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Figure 49. gCOSY spectrum of pulchrlalide B (42) (500 MHz, CDCl3) 
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Figure 50. gHMQC spectrum of pulchralide B (42) (500 MHz, CDCl3) 
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Figure 51. IR spectrum of pulchralide B (42) 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
150 200 250 300 350 400
wavelength
ab
so
rb
an
ce
 
Figure 52. UV spectrum of pulchralide B (42) 
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Figure 53.  LREI Mass spectrum of pulchralide B (42) 
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Figure 54. gHMQC spectrum of pulchralide C (43) (500 MHz CDCl3) 
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Figure 55. gHMBC spectrum of pulchralide C (43) (500 MHz, CDCl3) 
 
 
Figure 56. IR spectrum of pulchralide C (43) 
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Figure 57. UV spectrum of pulchralide C (43) 
 
 
Figure 58. LRESI Mass spectrum of pulchralide C (43) 
 85
